Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.70 EUR
17.28 M EUR
297.70 M EUR
12.17 M
About Fuji Pharma Co., Ltd.
Sector
Industry
Website
Headquarters
Tokyo
Founded
1954
ISIN
JP3816200004
FIGI
BBG000M14C38
Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. Its services include medical care for women; in vitro diagnostics; sale of acute medical care products and curative medicine; and provision of information on pharmaceuticals and health. The company was founded by Seiichi Imai in April 1954 and is headquartered in Tokyo, Japan.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Fuji Pharma Co., Ltd. stocks are traded under the ticker FUP.
We've gathered analysts' opinions on Fuji Pharma Co., Ltd. future price: according to them, FUP price has a max estimate of 13.82 EUR and a min estimate of 12.02 EUR. Watch FUP chart and read a more detailed Fuji Pharma Co., Ltd. stock forecast: see what analysts think of Fuji Pharma Co., Ltd. and suggest that you do with its stocks.
Yes, you can track Fuji Pharma Co., Ltd. financials in yearly and quarterly reports right on TradingView.
Fuji Pharma Co., Ltd. is going to release the next earnings report on Feb 5, 2026. Keep track of upcoming events with our Earnings Calendar.
Fuji Pharma Co., Ltd. revenue for the last quarter amounts to 84.82 M EUR, despite the estimated figure of 83.80 M EUR. In the next quarter, revenue is expected to reach 80.09 M EUR.
FUP net income for the last quarter is 6.74 M EUR, while the quarter before that showed 3.20 M EUR of net income which accounts for 110.73% change. Track more Fuji Pharma Co., Ltd. financial stats to get the full picture.
Fuji Pharma Co., Ltd. dividend yield was 2.75% in 2025, and payout ratio reached 34.57%. The year before the numbers were 3.57% and 18.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Fuji Pharma Co., Ltd. EBITDA is 51.59 M EUR, and current EBITDA margin is 17.33%. See more stats in Fuji Pharma Co., Ltd. financial statements.
Like other stocks, FUP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Fuji Pharma Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.